These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 26920014)

  • 1. Central N/OFQ-NOP Receptor System in Pain Modulation.
    Kiguchi N; Ding H; Ko MC
    Adv Pharmacol; 2016; 75():217-43. PubMed ID: 26920014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potentials of NOP and MOP receptor coactivation for the treatment of pain and opioid abuse.
    Kiguchi N; Ding H; Ko MC
    J Neurosci Res; 2022 Jan; 100(1):191-202. PubMed ID: 32255240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional plasticity of the N/OFQ-NOP receptor system determines analgesic properties of NOP receptor agonists.
    Schröder W; Lambert DG; Ko MC; Koch T
    Br J Pharmacol; 2014 Aug; 171(16):3777-800. PubMed ID: 24762001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic potentials of safe opioid analgesics targeting nociceptin/orphanin FQ peptide receptor].
    Kiguchi N; Kishioka S; Ko MC
    Nihon Yakurigaku Zasshi; 2021; 156(3):139-144. PubMed ID: 33952840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The therapeutic potential of nociceptin/orphanin FQ receptor agonists as analgesics without abuse liability.
    Lin AP; Ko MC
    ACS Chem Neurosci; 2013 Feb; 4(2):214-24. PubMed ID: 23421672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of NOP-Related Ligands in Nonhuman Primates.
    Kiguchi N; Ko MC
    Handb Exp Pharmacol; 2019; 254():323-343. PubMed ID: 30879202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nociceptin/Orphanin FQ Peptide Receptor-Related Ligands as Novel Analgesics.
    Kiguchi N; Ding H; Kishioka S; Ko MC
    Curr Top Med Chem; 2020; 20(31):2878-2888. PubMed ID: 32384033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of spinally administered bifunctional nociceptin/orphanin FQ peptide receptor/μ-opioid receptor ligands in mouse models of neuropathic and inflammatory pain.
    Sukhtankar DD; Zaveri NT; Husbands SM; Ko MC
    J Pharmacol Exp Ther; 2013 Jul; 346(1):11-22. PubMed ID: 23652222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nociceptin/orphanin FQ receptor and pain: Feasibility of the fourth opioid family member.
    Di Cesare Mannelli L; Micheli L; Ghelardini C
    Eur J Pharmacol; 2015 Nov; 766():151-4. PubMed ID: 26277324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supraspinal actions of nociceptin/orphanin FQ, morphine and substance P in regulating pain and itch in non-human primates.
    Ding H; Hayashida K; Suto T; Sukhtankar DD; Kimura M; Mendenhall V; Ko MC
    Br J Pharmacol; 2015 Jul; 172(13):3302-12. PubMed ID: 25752320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nociceptin Receptor-Related Agonists as Safe and Non-addictive Analgesics.
    Ding H; Kiguchi N; Dobbins M; Romero-Sandoval EA; Kishioka S; Ko MC
    Drugs; 2023 Jun; 83(9):771-793. PubMed ID: 37209211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of μ-opioid receptors and nociceptin/orphanin FQ peptide receptors in buprenorphine-induced physiological responses in primates.
    Cremeans CM; Gruley E; Kyle DJ; Ko MC
    J Pharmacol Exp Ther; 2012 Oct; 343(1):72-81. PubMed ID: 22743574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designing bifunctional NOP receptor-mu opioid receptor ligands from NOP-receptor selective scaffolds. Part II.
    Journigan VB; Polgar WE; Khroyan TV; Zaveri NT
    Bioorg Med Chem; 2014 Apr; 22(8):2508-16. PubMed ID: 24657054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nociceptin/orphanin FQ receptor activation attenuates antinociception induced by mixed nociceptin/orphanin FQ/mu-opioid receptor agonists.
    Khroyan TV; Polgar WE; Jiang F; Zaveri NT; Toll L
    J Pharmacol Exp Ther; 2009 Dec; 331(3):946-53. PubMed ID: 19713488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative study of [Tyr10]nociceptin/orphanin FQ (1-11) at NOP receptors in rat periaqueductal gray and expressed NOP receptors in HEK293 cells.
    Liao YY; Lee CW; Ho IK; Chiou LC
    Life Sci; 2012 Feb; 90(7-8):306-12. PubMed ID: 22213115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
    Witkin JM; Statnick MA; Rorick-Kehn LM; Pintar JE; Ansonoff M; Chen Y; Tucker RC; Ciccocioppo R
    Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-Based SAR in the Design of Selective or Bifunctional Nociceptin (NOP) Receptor Agonists.
    Meyer ME; Doshi A; Yasuda D; Zaveri NT
    AAPS J; 2021 May; 23(3):68. PubMed ID: 33974173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel orvinol analog, BU08028, as a safe opioid analgesic without abuse liability in primates.
    Ding H; Czoty PW; Kiguchi N; Cami-Kobeci G; Sukhtankar DD; Nader MA; Husbands SM; Ko MC
    Proc Natl Acad Sci U S A; 2016 Sep; 113(37):E5511-8. PubMed ID: 27573832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NOP-Related Mechanisms in Pain and Analgesia.
    Toll L; Ozawa A; Cippitelli A
    Handb Exp Pharmacol; 2019; 254():165-186. PubMed ID: 31119465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antinociceptive effects of nociceptin/orphanin FQ administered intrathecally in monkeys.
    Ko MC; Naughton NN
    J Pain; 2009 May; 10(5):509-16. PubMed ID: 19231294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.